loader
Please Wait
Applying Filters...

Bora CDMO Bora CDMO

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    List of Certificates of Suitability (CEPs) for r1_cep_2004_308___rev_05 Active Pharmaceutical Ingredient (API) issued by the EDQM. Original Data: EDQM Database

    Client Virtual Booth
    Menu

    Bayer AG

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    DOSSIERs // Finished Dosage Forms

    EXCIPIENTS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Phyton is a World Leader in Plant Cell Fermentation Technology and Commercial Manufacturing.

    Send me more info on How To Grow My Business Digitally?

    Left Arrow
    Right Arrow
    Filters Filter
    Cross PopUp
    FILTER :

    filter

    01 BAYER AG Leverkusen DE (1)

    filter

    01 Mesalazine (1)

    filter

    01 Germany (1)

    filter

    01 Withdrawn by Holder (1)

    ListList of Suppliers
    refresh Reset Filter
    refresh Reset Filter
    product-page Supplier Virtual Booth
    price-trend Ask Us

    BAYER AG Leverkusen DE

    Contact Supplier
    • FDA
    • EDQM
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag Germany
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Mesalazine

    PDF Supplier PDF
    URL Supplier Web Content
    R1-CEP 2004-308 - Rev 05
    Withdrawn by Holder
    Chemical
    2017-03-01
    2019-07-30
    1699
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content

    Looking for Certificates of Suitability (CEPs) for R1-CEP 2004-308 - Rev 05 of Bayer Ag Leverkusen De

    Looking for Certificates of Suitability (CEPs) for R1-CEP 2004-308 - Rev 05 of Bayer Ag Leverkusen De 1

    20

    Bayer Ag Leverkusen De, based in Germany, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.

    One of their significant offerings is Mesalazine, supported by a 'Withdrawn by Holder' Certificate of Suitability (CEP) with the number R1-CEP 2004-308 - Rev 05

    This Chemical Type CEP, issued on March 01, 2017, remains in force until July 30, 2019, ensuring its reliability within the pharmaceutical industry.

    Substance Number 1699 associated with this CEP further emphasizes

    Post Enquiry
    POST ENQUIRY